This effect has been shown on a clinical scale, with infusion of pooled human serum IgA reducing inflammation in synovial infiltrates in rheumatoid arthritis as well as reducing symptoms of arthritis in human FcαR transgenic mice [64]. This evidence concerns the gene FCAR and arthritic joint disease.